A total of 314 subjects with history of migraine , with or without aura , were randomized to frovatriptan 2.5 mg alone ( Frova ) , frovatriptan 2.5 mg + dexketoprofen 25 mg ( FroDex25 ) or frovatriptan 2.5 mg + dexketoprofen 37.5 mg ( FroDex37 .5 ) and treated at least one migraine attack .